Skip to content
healthcare.dev
Get a free key

DYANAVEL XR

NDC 24478-110, amphetamine, tablet, extended release, from NextWave Pharmaceuticals, Inc.

Product NDC
24478-110
Status
Listed
Labeler
NextWave Pharmaceuticals, Inc
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA210526
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/24478-110 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMPHETAMINE20 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
24478-110-012447801100130 TABLET, EXTENDED RELEASE in 1 BOTTLE (24478-110-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ae304b29-0b40-40ec-ad0d-76b742d4a9b9

  • NADAC price for package 24478011001

    GET /v1/drugs/nadac/24478011001

Use it

Look up 24478-110 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/24478-110 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 24478-110. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.